Skip to content

Leafs prospect Amirov undergoing treatment in Germany for brain tumour

20220223090236-aa466977a698d2acaa9d2d303804b8a6209ab1426ae71fcba71a9c257459af40
Toronto Maple Leafs prospect Rodion Amirov has been diagnosed with a brain tumour. Maple Leafs general manager Kyle Dubas in a statement Wednesday that Amirov is undergoing treatment in Germany. Amirov celebrates his goal on a penalty shot against Austria at the IIHF World Junior Hockey Championship action in Edmonton on Tuesday, December 29, 2020. THE CANADIAN PRESS/Jason Franson

Toronto Maple Leafs prospect Rodion Amirov has been diagnosed with a brain tumour.

Maple Leafs general manager Kyle Dubas said in a statement Wednesday that Amirov is undergoing treatment in Germany and will not return for the remainder of the season.

Agent Dan Milstein said Amirov is skating three times a week and working out daily while with his family in Germany.

“Rodion is in good spirits and is determined to return back to professional hockey,” Milstein said.

Amirov started the season with Salavat Ufa of the Russia-based Kontinental Hockey League and was injured 10 games in. 

Dubas said Amrirov developed unrelated symptoms over the course of his recovery that required "ongoing extensive investigations."

The Maple Leafs selected Amirov with the 15th pick of the 2020 NHL draft.

"Our medical staff has been involved throughout the process alongside Ufa's and we are in direct contact with the facility on an ongoing basis to monitor his treatment and care," Dubas said.

"Rodion has the complete support of the Toronto Maple Leafs organization and we will continue to ensure he receives the best care possible throughout this process."

-- With files from The Associated Press.

This report by The Canadian Press was first published Feb. 23, 2022.

The Canadian Press


Looking for National Sports News?

VillageReport.ca viewed on a mobile phone

Check out Village Report - the news that matters most to Canada, updated throughout the day.  Or, subscribe to Village Report's free daily newsletter: a compilation of the news you need to know, sent to your inbox at 6AM.

Subscribe